Related Experiment Video
Updated: Apr 25, 2026

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
Published on: March 10, 2017
Hepatic macrophage activation and the LPS pathway in patients with alcoholic hepatitis: a prospective cohort study
Thomas Damgaard Sandahl1, Henning Grønbaek1, Holger Jon Møller2
1Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Objectives:
Inflammatory activation of resident hepatic macrophages (Kupffer cells) by portal-derived lipopolysaccharide (LPS) has a primary role in animal models of alcoholic liver disease, but it has not been systematically or longitudinally studied in human alcoholic hepatitis (AH).
Methods:
We followed 50 patients with AH for 30 days. 26 patients with stable alcoholic cirrhosis and 20 healthy individuals were controls. We measured the plasma (P) concentrations of soluble CD163 (sCD163; a specific marker of inflammatory macrophage activation) and the expression of CD163 in liver tissue by immunohistochemistry and stereology of liver biopsies. We also measured the key components of the LPS pathway, P-LPS, sCD14, and LPS-binding protein (LBP), by enzyme-linked immunosorbent assay (ELISA). The 84-day mortality was registered.
Results:
At study entry, the sCD163 concentration was 10-fold higher than in the healthy controls and 30% higher than in the stable cirrhotics (P<0.002), and it correlated with the Glasgow Alcoholic Hepatitis, Model for End-stage Liver Disease, and Child-Pugh scores (r>0.35, P<0.02, all). The liver biopsies confirmed markedly increased CD163 staining (P<0.01). P-LPS, P-CD14, and P-LBP were increased to the same degree as sCD163. During the follow-up, the sCD163 and LPS pathway components all decreased by ∼25% (P<0.05) but remained higher than in both control groups. sCD163 was an independent predictor of the 84-day mortality.
Conclusions:
The hepatic inflammation of human AH involves marked activation of hepatic macrophages, likely via the LPS pathway. Hepatic macrophages may thus present a target for biological therapy of AH.
Insights
In human alcoholic hepatitis (AH), hepatic macrophages show significant inflammatory activation, likely driven by lipopolysaccharide (LPS). This macrophage activation is a predictor of mortality and a potential therapeutic target.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Inflammatory activation of Kupffer cells by lipopolysaccharide (LPS) is crucial in animal models of alcoholic liver disease.
- This process has not been systematically studied in human alcoholic hepatitis (AH).
Purpose of the Study:
- To investigate the longitudinal changes in hepatic macrophage activation and LPS pathway components in patients with AH.
- To assess the correlation of these markers with disease severity and mortality.
Main Methods:
- Longitudinal study of 50 AH patients over 30 days, with controls including 26 stable cirrhotics and 20 healthy individuals.
- Measurement of plasma soluble CD163 (sCD163), liver CD163 expression, plasma LPS, sCD14, and LPS-binding protein (LBP).
- Correlation analysis with clinical scores (Glasgow AH, MELD, Child-Pugh) and 84-day mortality.
Main Results:
- Patients with AH exhibited significantly elevated sCD163 and LPS pathway markers compared to controls.
- sCD163 levels correlated with AH severity scores.
- Markers decreased during follow-up but remained elevated; sCD163 independently predicted 84-day mortality.
Conclusions:
- Human AH involves significant hepatic macrophage activation, likely mediated by the LPS pathway.
- Hepatic macrophages represent a potential therapeutic target for biological treatment of AH.
More Related Videos
Related Concept Videos
Cirrhosis II: Pathophysiology
Inflammation
Chronic Pancreatitis II: Pathophysiology
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Chronic Inflammation: Introduction
Cirrhosis I: Introduction

